Others, for example, podoplanin (PDPN), have been associated with improved prognosis in CRC, with PDPN-positive CAFs being related to decreased depth of tumor invasion, and their location is in the tumor center rather than at the invasion front (13). This evidence concerns the gene PDPN and colorectal carcinoma.